Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours
Purpose In vivo imaging of the spread of oncolytic viruses using the Na/I symporter (NIS) has been proposed. Here, we assessed whether the presence of NIS in the viral genome affects the therapeutic efficacy of the oncolytic adenovirus dl922-947 following intraperitoneal administration, in a mouse m...
Saved in:
Published in | European journal of nuclear medicine and molecular imaging Vol. 37; no. 7; pp. 1377 - 1385 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer-Verlag
01.07.2010
Springer Nature B.V Springer Verlag (Germany) [1976-....] |
Subjects | |
Online Access | Get full text |
ISSN | 1619-7070 1619-7089 1619-7089 |
DOI | 10.1007/s00259-009-1379-3 |
Cover
Summary: | Purpose
In vivo imaging of the spread of oncolytic viruses using the Na/I symporter (NIS) has been proposed. Here, we assessed whether the presence of
NIS
in the viral genome affects the therapeutic efficacy of the oncolytic adenovirus
dl922-947
following intraperitoneal administration, in a mouse model of peritoneal ovarian carcinoma.
Methods
We generated AdAM7, a
dl922-947
oncolytic adenovirus encoding the
NIS
coding sequence. Iodide uptake, NIS expression, infectivity and cell-killing activity of AdAM7, as well as that of relevant controls, were determined in vitro. In vivo, the propagation of this virus in the peritoneal cavity of tumour-bearing mice was determined using SPECT/CT imaging and its therapeutic efficacy was evaluated.
Results
In vitro infection of ovarian carcinoma IGROV-1 cells with ADAM7 led to functional expression of NIS. However, the insertion of
NIS
into the viral genome resulted in a loss of efficacy of the virus in terms of replication and cytotoxicity. In vivo, on SPECT/CT imaging AdAM7 was only detectable in the peritoneal cavity of animals bearing peritoneal ovarian tumours for up to 5 days after intraperitoneal administration. Therapeutic experiments in vivo demonstrated that AdAM7 is as potent as its NIS-negative counterpart.
Conclusion
This study demonstrated that despite the detrimental effect observed in vitro, insertion of the reporter gene
NIS
in an oncolytic adenovirus did not affect its therapeutic efficacy in vivo. We conclude that
NIS
is a highly relevant reporter gene to monitor the fate of oncolytic adenovectors in live subjects. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 1619-7070 1619-7089 1619-7089 |
DOI: | 10.1007/s00259-009-1379-3 |